Blood iron, glutathione, and micronutrient levels and the risk of oral cancer

Nutrition and Cancer

Volumn 60, Issue 4, 2008, Pages 474-482

  Richie Jr , John P ^a   Kleinman, Wayne ^b   Marina, Patricia ^c   Abraham, Patricia ^c   Wynder, Ernst L ^c   Muscat, Joshua E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; FERRITIN; FOLIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; HEMOGLOBIN; IRON; RETINOL; RIBOFLAVIN; THIAMINE; TRANSFERRIN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OXIDATIVE STRESS; RISK ASSESSMENT; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FERRITINS; GLUTATHIONE; HUMANS; IRON; MALE; MICRONUTRIENTS; MIDDLE AGED; MOUTH NEOPLASMS; ODDS RATIO; OXIDATIVE STRESS; RISK FACTORS; SMOKING; TRANSFERRIN;

EID: 46349103750     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580801956477     Document Type: Article

References (88)

1. Davies L and Welch HG: Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 135, 451-457, 2006.
2. Mignogna MD, Fedele S, and Lo Russo L: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev 13, 139-142, 2004.
3. Cann CI, Fried MP, and Rothman KJ: Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin North Am 18, 367-388, 1985.
4. McCoy GD and Wynder EL: Etiological and preventive implications in alcohol carcinogenesis. Cancer Res 39, 2844-2850, 1979.
5. Hoffmann D and Hecht SS: Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res 45, 935-944, 1985.
6. Warnakulasuriya S, Sutherland G, and Scully C: Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41, 244-260, 2005.
7. Marshall JR and Boyle P: Nutrition and oral cancer. Cancer Causes Control 7, 101-111, 1996.
8. Winn DM: Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr 61, 437S-445S, 1995.
9. Wynder EL, Hultberg S, Jacobsson F, and Bross IJ: Environmental factors in cancer of the upper alimentary tract; a Swedish study with special reference to Plummer-Vinson (Paterson-Kelly) syndrome. Cancer 10, 470-487, 1957.
10. Novacek G: Plummer-Vinson syndrome. Orphanet J Rare Dis 1, 36, 2006.
11. Larsson LG, Sandstrom A, and Westling P: Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden. Cancer Res 35, 3308-3316, 1975.
12. Petridou E, Zavras AI, Lefatzis D, Dessypris N, Laskaris G, et al.: The role of diet and specificmicronutrients in the etiology of oral carcinoma. Cancer 94, 2981-2988, 2002.
13. Negri E, Franceschi S, Bosetti C, Levi F, Conti E, et al.: Selected micronutrients and oral and pharyngeal cancer. Int J Cancer 86, 122-127, 2000.
14. Rogers MA, Thomas DB, Davis S, Vaughan TL, and Nevissi AE: A case-control study of element levels and cancer of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 2, 305-312, 1993.
15. Gupta PC, Hebert JR, Bhonsle RB, Murti PR, Mehta H, et al.: Influence of dietary factors on oral precancerous lesions in a population-based case-control study in Kerala, India. Cancer 85, 1885-1893, 1999.
16. Prime SS, MacDonald DG, and Rennie JS: The effect of iron deficiency on experimental oral carcinogenesis in the rat. Br J Cancer 47, 413-418, 1983.
17. Prime SS, MacDonald DG, Sawyer DR, and Rennie J: The effect of iron deficiency on early oral carcinogenesis in the rat. JOral Pathol 15, 265-267, 1986.
18. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344, 721-724, 1994.
19. Aslan M, Horoz M, Kocyigit A, Ozgonul S, Celik H, et al.: Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Mutat Res 601, 144-149, 2006.
20. Aust AE and Eveleigh JF: Mechanisms of DNA oxidation. Proc Soc Exp Biol Med 222, 246-252, 1999.
21. Vives Corrons JL, Miguel-Garcia A, Pujades MA, Miguel-Sosa A, Cambiazzo S, et al.: Increased susceptibility of microcytic red blood cells to in vitro oxidative stress. Eur J Haematol 55, 327-331, 1995.
22. Kumerova A, Lece A, Skesters A, Silova A, and Petuhovs V: Anaemia and antioxidant defence of the red blood cells. Mater Med Pol 30, 12-15, 1998.
23. Macdougall LG: Red cell metabolism in iron deficiency anemia. 3. The relationship between glutathione peroxidase, catalase, serum vitamin E, and susceptibility of iron-deficient red cells to oxidative hemolysis. J Pediatr 80, 775-782, 1972.
24. Huang Z, Komninou D, Kleinman W, Pinto JT, Gilhooly EM, et al.: Enhanced levels of glutathione and protein glutathiolation in rat tongue epithelium during 4-NQO-induced carcinogenesis. Int J Cancer 120, 1396-1401, 2007.
25. Stich HF and Anders F: The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. Mutat Res 214, 47-61, 1989.
26. Subapriya R, Kumaraguruparan R, Ramachandran CR, and Nagini S: Oxidant-antioxidant status in patients with oral squamous cell carcinomas at different intraoral sites. Clin Biochem 35, 489-493, 2002.
27. Zain RB: Cultural and dietary risk factors of oral cancer and precancer - a brief overview. Oral Oncol 37, 205-210, 2001.
28. Riboli E and Norat T: Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 78, 559S-569S, 2003.
29. Chainani-Wu N: Diet and oral, pharyngeal, and esophageal cancer. Nutr Cancer 44, 104-126, 2002.
30. El-Bayoumy K, Chung FL, Richie J Jr., Reddy BS, Cohen L, et al.: Dietary control of cancer. Proc Soc Exp Biol Med 216, 211-223, 1997.
31. Garewal H, Meyskens F Jr, Friedman S, Alberts D, and Ramsey L: Oral cancer prevention: the case for carotenoids and anti-oxidant nutrients. Prev Med 22, 701-711, 1993.
32. Locigno R and Castronovo V: Reduced glutathione system: role in cancer development, prevention and treatment (review). Int J Oncol 19, 221-236, 2001.
33. Hamilos DL and Wedner HJ: The role of glutathione in lymphocyte activation: I. comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J Immunol 135, 2740-2747, 1985.
34. Wu G, Fang YZ, Yang S, Lupton JR, and Turner ND: Glutathione metabolism and its implications for health. J Nutr 134, 489-492, 2004.
35. Manoharan S, Kolanjiappan K, Suresh K, and Panjamurthy K: Lipid peroxidation and antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res 122, 529-534, 2005.
36. Fiaschi AI, Cozzolino A, Ruggiero G, and Giorgi G: Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 9, 361-367, 2005.
37. Flagg EW, Coates RJ, Eley JW, Jones DP, Gunter EW, et al.: Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level. Nutr Cancer 21, 33-46, 1994.
38. Garry PJ, Hunt WC, and Baumgartner RN: Effects of iron intake on iron stores in elderly men and women: longitudinal and cross-sectional results. J Am Coll Nutr 19, 262-269, 2000.
39. Brittenham G: Spectrophotometric plasma iron determination from finger puncture specimens. Clin Chim Acta 91, 203-211, 1979.
40. Cook JD: An evaluation of adsorption methods for measurement of plasma iron-binding capacity. J Lab Clin Med 76, 497-506, 1970.
41. Cook JD, Lipschitz DA, Miles LE, and Finch CAL Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 27, 681-687, 1974.
42. Drabkin DL: The standardization of haemoglobin measurement. Am J Med Sci 217, 710-711, 1949.
43. Milne DB and Botnen J: Retinol, alpha-tocopherol, lycopene, and alpha-and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 32, 874-876, 1986.
44. Sauberlich HE, Judd JH Jr., Nichoalds GE, Broquist HP, and Darby WJ: Application of the erythrocyte glutathione reductase assay in evaluating riboflavin nutritional status in a high school student population. Am J Clin Nutr 25, 756-762, 1972.
45. Smeets EH, Muller H, and de Wael J: A NADH-dependent transketolase assay in erythrocyte hemolysates. Clin Chim Acta 33, 379-386, 1971.
46. Aihara K, Nishi Y, Hatano S, Kihara M, Yoshimitsu K, et al.: Zinc, copper, manganese, and selenium metabolism in thyroid disease. Am J Clin Nutr 40, 26-35, 1984.
47. Kleinman WA and Richie JP Jr.: Determination of thiols and disulfides using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 672, 73-80, 1995.
48. Haley NJ, Axelrad CM, and Tilton KA: Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am J Public Health 73, 1204-1207, 1983.
49. Dale JC, Burritt MF, and Zinsmeister AR: Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol 117, 802-808, 2002.
50. Torti SV and Torti FM: Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 10, 119-137, 1994.
51. Weiss G and Goodnough LT: Anemia of chronic disease. N Engl J Med 352, 1011-1023, 2005.
52. Kurokawa H, Tsuru S, Okada M, Nakamura T, and Kajiyama M: Evaluation of tumormarkers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 22, 35-38, 1993.
53. Inal E, Lacin M, Asal K, Ceylan A, Koybasioglu A, et al.: The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Kulak Burun Bogaz Ihtis Derg 12, 23-30, 2004.
54. Lieu PT, Heiskala M, Peterson PA, and Yang Y: The roles of iron in health and disease. Mol Aspects Med 22, 1-87, 2001.
55. Ulbrich EJ, Lebrecht A, Schneider I, Ludwig E, Koelbl H, et al.: Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res 23, 5107-5109, 2003.
56. Eshhar Z, Order SE, and Katz DH: Ferritin, a Hodgkin's disease associated antigen. Proc Natl Acad Sci USA 71, 3956-3960, 1974.
57. Rubin C, Wood PJ, Archer T, and Rowe DJ: Changes in serum ferritin and other 'acute phase' proteins following major surgery. Ann Clin Biochem 21(Pt 4), 290-294, 1984.
58. Whitfield JB, Treloar S, Zhu G, Powell LW, and Martin NG: Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br J Haematol 120, 860-866, 2003.
59. Zacharski LR, Ornstein DL, Woloshin S, and Schwartz LM: Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 140, 98-104, 2000.
60. Alberg A: The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180, 121-137, 2002.
61. Schantz SP and Yu GP: Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128, 268-274, 2002.
62. Ng SK, Kabat GC, and Wynder EL: Oral cavity cancer in non-users of tobacco. J Natl Cancer Inst 85, 743-745, 1993.
63. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, et al.: Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer 80, 693-698, 1999.
64. Rajendran R, Vasudevan DM, and Vijayakumar T: Serum levels of iron and proteins in oral submucous fibrosis (OSMF). Ann Dent 49, 23-25, 1990.
65. Flagg EW, Coates RJ, Jones DP, Byers TE, Greenberg RS, et al.: Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol 139, 453-465, 1994.
66. Sies H: Glutathione and its role in cellular functions. Free Radic Biol Med 27, 916-921, 1999.
67. Coles B and Ketterer B: The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25, 47-70, 1990.
68. Townsend DM, Tew KD, and Tapiero H: The importance of glutathione in human disease. Biomed Pharmacother 57, 145-155, 2003.
69. Trickler D, Shklar G, and Schwartz J: Inhibition of oral carcinogenesis by glutathione. Nutr Cancer 20, 139-144, 1993.
70. Schwartz JL and Shklar G: Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr Cancer 26, 229-236, 1996.
71. Marshall J, Graham S, Mettlin C, Shedd D, and Swanson M: Diet in the epidemiology of oral cancer. Nutr Cancer 3, 145-149, 1982.
72. Hoppel C, DiMarco JP, and Tandler B: Riboflavin and rat hepatic cell structure and function: mitochondrial oxidative metabolism in deficiency states. J Biol Chem 254, 4164-4170, 1979.
73. Brady PS and Hoppel CL: Hepatic peroxisomal and mitochondrial fatty acid oxidation in the riboflavin-deficient rat. Biochem J 229, 717-721, 1985.
74. Fass S and Rivlin RS: Regulation of riboflavin-metabolizing enzymes in riboflavin deficiency. Am J Physiol 217, 988-991, 1969.
75. Sirivech S, Driskell J, and Frieden E: NADH-FMN oxidoreductase activity and iron content of organs from riboflavin and iron-deficient rats. J Nutr 107, 739-745, 1977.
76. Powers HJ, Bates CJ, and Duerden JM: Effects of riboflavin deficiency in rats on some aspects of iron metabolism. Int J Vitam Nutr Res 53, 371-376, 1983.
77. Powers HJ: Investigation into the relative effects of riboflavin deprivation on iron economy in the weanling rat and the adult. Ann Nutr Metab 30, 308-315, 1986.
78. Wynder EL and Klein UE: The possible role of riboflavin deficiency in epithelial neoplasia: I. epithelial changes of mice in simple deficiency. Cancer 18, 167-180, 1965.
79. Wynder EL and Chan PC: The possible role of riboflavin deficiency in epithelial neoplasia: II. effect of skin tumor development. Cancer 26, 1221-1224, 1970.
80. Chan PC, Okamoto T, and Wynder EL: Possible role of riboflavin deficiency in epithelial neoplasia: 3. induction of microsomal aryl hydrocarbon hydroxylase. J Natl Cancer Inst 48, 1341-1345, 1972.
81. Zheng W, Sellers TA, Doyle TJ, Kushi LH, Potter JD, et al.: Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women. Am J Epidemiol 142, 955-960, 1995.
82. Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, et al.: Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol 36, 466-470, 2000.
83. Zheng W, Blot WJ, Diamond EL, Norkus EP, Spate V, et al.: Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Res 53, 795-798, 1993.
84. Rivlin RS: Regulation of flavoprotein enzymes in hypothyroidism and in riboflavin deficiency. Adv Enzyme Regul 8, 239-250, 1970.
85. Lu SC: Regulation of glutathione synthesis. Curr Top Cell Regu 36, 95-116, 2000.
86. Muscat JE, Kleinman W, Colosimo S, Muir A, Lazarus P, et al.: Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic Biol Med 36, 464-470, 2004.
87. Richie JP Jr., Abraham P, and Leutzinger Y: Long-term stability of blood glutathione and cysteine in humans. Clin Chem 42, 1100-1105, 1996.
88. Richie JP Jr., Skowronski L, Abraham P, and Leutzinger Y: Blood glutathione concentrations in a large-scale human study. Clin Chem 42, 64-70, 1996.